South Korea: SK Bioscience to develop COVID-flu combo vaccine - ETHealthworld.com

3:10am PST - February 22nd, 2022    health - The Times of India

Currently, the infection rate of the flurona is low, but the mortality rate is six times higher than uninfected people and 2.3 times higher than patients with only COVID-19.